Comparative Pharmacokinetic of S221237 Tablets in Healthy Participants Under Fed Conditions

2024-511270-72-00 Protocol S221237-176 Human pharmacology (Phase I) - Other Ended

Start 13 Jun 2024 · End 21 Jul 2024 · Status Ended · 1 EU/EEA countries · 1 sites · Protocol S221237-176

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - Other
Status Ended
Participants planned 16
Countries 1
Sites 1

No medical condition

Key facts

Sponsor
Institut De Recherches Internationales Servier IRIS, Institut De Recherches Internationales Servier IRIS
Participant type
Healthy volunteers
Age range
18-64 years
Gender
Male
Therapeutic area
Not possible to specify
Trial duration
13 Jun 2024 → 21 Jul 2024
Decision date (initial)
2024-06-04
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

No medical condition

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Institut De Recherches Internationales Servier IRIS

Sponsor organisation
Institut De Recherches Internationales Servier IRIS
Address
22 Route 128
City
Gif Sur Yvette
Postcode
91190
Country
France

Scientific contact point

Organisation
Institut De Recherches Internationales Servier IRIS
Contact name
Clinical Studies Department

Public contact point

Organisation
Institut De Recherches Internationales Servier IRIS
Contact name
Clinical Studies Department

Institut De Recherches Internationales Servier IRIS

Sponsor organisation
Institut De Recherches Internationales Servier IRIS
Address
22 Route 128
City
Gif Sur Yvette
Postcode
91190
Country
France

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Portugal Ended 16 1
Rest of world 0

Investigational sites

Portugal

1 site · Ended
Blueclinical Investigacao E Desenvolvimento Em Saude Lda.
Medical Management, Hospital Da Prelada 0 Floor And 3 rd Floor, Rua Sarmento De Beires 153, Porto

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Portugal 2024-06-13 2024-07-21 2024-06-13 2024-06-19

Application history

2 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-04-03 Portugal Acceptable
2024-06-03
2024-06-04
2 NON SUBSTANTIAL MODIFICATION NSM-1 2024-06-28 Portugal Acceptable
2024-06-03
2024-06-28